Nöromüsküler Hastalıklarda Görüntüleme Bulguları

Dowling JJ, D Gonorazky H, Cohn RD, Campbell C. Treating pediatric neuromuscular disorders: The future is now. Am J Med Genet A. 2018 Apr;176(4):804-841.

Romitti PA, Zhu Y, Puzhankara S, et al. Prevalence of Duchenne and Becker muscular dystrophies in the United States [published correction appears in Pediatrics. 2015 May;135(5):945]. Pediatrics. 2015;135(3):513-521.

Topaloglu H. Epidemiology of muscular dystrophies in the Mediterranean area. Acta Myol. 2013;32(3):138-141.

Warman-Chardon J, Straub V. The Role of Muscle Imaging in the Diagnosis and Assessment of Children with Genetic Muscle Disease. Neuropediatrics. 2017 Aug;48(4):233-241.

Caetano AP, Alves P. Advanced MRI Patterns of Muscle Disease in Inherited and Acquired Myopathies: What the Radiologist Should Know. Semin Musculoskelet Radiol. 2019;23(3):e82-e106.

Wattjes MP, Kley RA, Fischer D. Neuromuscular imaging in inherited muscle diseases. Eur Radiol. 2010 Oct;20(10):2447-60.

Diaz-Manera J, Pichiecchio A, Santini F, Filosto M. Editorial: Imaging of Neuromuscular Diseases. Front Neurol. 2021 Dec 2;12:814579.

Wijntjes J, van Alfen N. Muscle ultrasound: Present state and future opportunities. Muscle Nerve. 2021 Apr;63(4):455-466.

Simon NG, Noto YI, Zaidman CM. Skeletal muscle imaging in neuromuscular disease. J Clin Neurosci. 2016 Nov;33:1-10.

Sudoł-Szopińska I, Jacques T, Gietka P, Cotten A. Imaging in dermatomyositis in adults and children. J Ultrason. 2020;20(80):e36-e42.

Willcocks RJ, Rooney WD, Triplett WT, et al. Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large Duchenne muscular dystrophy cohort. Ann Neurol 2016; 79(04):535–547.

Bonati U, Hafner P, Schädelin S, et al. Quantitative muscle MRI: a powerful surrogate outcome measure in Duchenne muscular dystrophy. Neuromuscul Disord 2015;25(09):679–685.

Fischmann A, Hafner P, Gloor M, et al. Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy. J Neurol 2013;260(04):969–974.

Hollingsworth KG, Garrood P, Eagle M, Bushby K, Straub V. Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months. Muscle Nerve 2013;48(04):586–588.

Willcocks RJ, Arpan IA, Forbes SC, et al. Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression. Neuromuscul Disord 2014;24(05):393–401.

Faridian-Aragh N, Wagner KR, Leung DG, Carrino JA. Magnetic resonance imaging phenotyping of Becker muscular dystrophy. Muscle Nerve 2014;50(06):962–967.

Straub V, Bushby K. The childhood limb-girdle muscular dystrophies. Semin Pediatr Neurol. 2006 Jun;13:104-114.

Straub V, Murphy A, Udd B; LGMD workshop study group. 229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscul Disord. 2018 Aug;28(8):702-710.

ten Dam L, van der Kooi AJ, van Wattingen M, de Haan RJ, de Visser M . Reliability and accuracy of skeletal muscle imaging in limb girdle muscular dystrophies. Neurology. 2012;79(16):1716 1723.

Tasca G, Monforte M, Diaz Manera J, et al. MRI in sarcoglycanopathies: a large international cohort study. J Neurol Neurosurg Psychiatry. 2018;89(1):72 77.

Paradas C, Llauger J, Diaz Manera J, et al. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology. 2010;75(4):316 323.

Mercuri E, Talim B, Moghadaszadeh B, et al. Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromuscul Disord. 2002 Oct;12(7-8):631-638.

Bertini E, D'Amico A, Gualandi F, Petrini S. Congenital muscular dystrophies: a brief review. Semin Pediatr Neurol. 2011 Dec;18(4):277-288.

Graziano A, Bianco F, D'Amico A, et al. Prevalence of congenital muscular dystrophy in Italy: a population study. Neurology. 2015 Mar 3;84(9):904-11.

Mah JK, Korngut L, Fiest KM, et al. A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies. Can J Neurol Sci. 2016 Jan;43(1):163-77.

Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009 Nov;132(Pt 11):3175-86.

O'Grady GL, Lek M, Lamande SR, et al. Diagnosis and etiology of congenital muscular dystrophy: We are halfway there. Ann Neurol. 2016 Jul;80(1):101-11.

Kang PB, Morrison L, Iannaccone ST, et al. .Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology. 2015 Mar 31;84(13):1369-78.

Bönnemann CG, Wang CH, Quijano-Roy S, et al. Members of International Standard of Care Committee for Congenital Muscular Dystrophies. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014 Apr;24(4):289-311.

Sarkozy A, Torelli S, Mein R, et al. Mobility shift of beta-dystroglycan as a marker of GMPPB gene-related muscular dystrophy. J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):762-768.

Barkovich AJ. Neuroimaging manifestations and classification of congenital muscular dystrophies. AJNR Am J Neuroradiol. 1998 Sep;19(8):1389-1396.

Tubridy N, Fontaine B, Eymard B. Congenital myopathies and congenital muscular dystrophies. Curr Opin Neurol. 2001 Oct;14(5):575-82.

North KN, Wang CH, Clarke N, et al. International Standard of Care Committee for Congenital Myopathies. Approach to the diagnosis of congenital myopathies. Neuromuscul Disord. 2014 Feb;24(2):97-116.

Butterfield RJ. Congenital Muscular Dystrophy and Congenital Myopathy. Continuum (Minneap Minn). 2019;25(6):1640-1661.

Mercuri E, Pera MC, Brogna C. Neonatal hypotonia and neuromuscular conditions. Handb Clin Neurol. 2019;162:435-448.

Mercuri E, Clements E, Offiah A, et al. Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol. 2010 Feb;67(2):201-208.

Klein A, Jungbluth H, Clement E, et al. Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations. Arch Neurol. 2011;68(9):1171 1179.

Warman-Chardon J, Diaz-Manera J, Tasca G, Straub V. MRI workshop study group. 247th ENMC International Workshop: Muscle magnetic resonance imaging - Implementing muscle MRI as a diagnostic tool for rare genetic myopathy cohorts. Hoofddorp, The Netherlands, September 2019. Neuromuscul Disord. 2020 Nov;30(11):938-947.

Harris E, McEntagart M, Topf A, et al. Clinical and neuroimaging findings in two brothers with limb girdle muscular dystrophy due to LAMA2 mutations. Neuromuscul Disord. 2017;27(2):170 174.

Pisciotta C, Shy ME. (2023). Hereditary neuropathy. Handbook of Clinical Neurology, Vol 195. Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders. Elsevier B.V. 2023.p.609-617. https://doi.org/10.1016/B978-0-323-98818-6.00009-1.

Kim HS, Kim HJ, Nam SH, et al. Clinical and Neuroimaging Features in Charcot-Marie-Tooth Patients with GDAP1 Mutations. J Clin Neurol. 2021 Jan;17(1):52-62.

Aho TR, Wallace RC, Pitt AM, Sivakumar K. Charcot-Marie-Tooth disease: extensive cranial nerve involvement on CT and MR imaging. AJNR Am J Neuroradiol. 2004 Mar;25(3):494-497.

Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain‐Barré syndrome: a systematic review and meta‐analysis. Neuroepidemiology. 2011;36:123‐33.

Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717-727.

Korinthenberg R, Trollmann R, Felderhoff-Müser U, et al. Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence- and consensus-based guideline. Eur J Paediatr Neurol. 2020 Mar;25:5-16.

Baran GA, Sowell MK, Sharp GB, Glasier CM. MR findings in a child with Guillain-Barré syndrome. AJR Am J Roentgenol. 1993 Jul;161(1):161-3.

Liu L, Ye Y, Wang L, Song X, Cao J, Qi Y, Xing Y. Nerve ultrasound evaluation of Guillain-Barré syndrome subtypes in northern China. Muscle Nerve. 2021 Nov;64(5):560-566.

Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision [published correction appears in J Peripher Nerv Syst. 2022 Mar;27(1):94] [published correction appears in Eur J Neurol. 2022 Apr;29(4):1288]. J Peripher Nerv Syst. 2021;26(3):242-268.

Sarıkaya Uzan G, Vural A, Yüksel D, et al. Pediatric-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A Multicenter Study. Pediatr Neurol. 2023 Aug;145:3-10.

Di Pasquale A, Morino S, Loreti S, Bucci E, Vanacore N, Antonini G. Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity. Neurology. 2015 Feb 24;84(8):803-9.

Mammen AL. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol. 2011;7(6):343-354. Published 2011 Jun 8. doi:10.1038/nrneurol.2011.63

Schulze M, Kötter I, Ernemann U, et al. MRI findings in inflammatory muscle diseases and their noninflammatory mimics. AJR Am J Roentgenol. 2009 Jun;192(6):1708-16.

Yoshida K, Kurosaka D, Joh K, et al. Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging. Arthritis Rheum. 2010;62(12):3751-3759.

Del Grande F, Carrino JA, Del Grande M, Mammen AL, Christopher Stine L. Magnetic resonance imaging of inflammatory myopathies. Top Magn Reson Imaging. 2011;22(2):39-43. 55. Schulze M, Kötter I, Ernemann U, et al. MRI findings in inflammatory muscle diseases and their noninflammatory mimics. AJR Am J Roentgenol. 2009 Jun;192(6):1708-1716.

Yiş U, Uyanik G, Rosendahl DM, et al. Clinical, radiological, and genetic survey of patients with muscle-eye-brain disease caused by mutations in POMGNT1. Pediatr Neurol. 2014;50(5):491-497.

Böhm J, Yiş U, Ortaç R, et al. Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation. Orphanet J Rare Dis. 2010;5:35.